Duality Advisers, LP Ptc Therapeutics, Inc. Transaction History

Duality Advisers, LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$24.15 - $31.95 $65,784 - $87,031	2,724 Added 5.85%	49,322 $1.43 Million
Q4 2023 Feb 01, 2024	BUY	$18.07 - $29.37 $191,993 - $312,056	10,625 Added 29.54%	46,598 $1.28 Million
Q3 2023 Nov 02, 2023	BUY	$22.41 - $41.99 $3,249 - $6,088	145 Added 0.4%	35,973 $806,000
Q2 2023 Jul 31, 2023	BUY	$40.4 - $59.1 $1.04 Million - $1.52 Million	25,800 Added 257.28%	35,828 $1.46 Million
Q1 2023 Jun 27, 2023	SELL	$38.16 - $48.86 $894,165 - $1.14 Million	-23,432 Reduced 70.03%	10,028 $485,000
Q4 2022 Feb 07, 2023	SELL	$33.53 - $54.79 $56,900 - $92,978	-1,697 Reduced 4.83%	33,460 $1.28 Million
Q3 2022 Nov 03, 2022	BUY	$41.85 - $53.85 $1.47 Million - $1.89 Million	35,157 New	35,157 $1.77 Million
Q2 2022 Aug 08, 2022	SELL	$25.6 - $45.23 $571,648 - $1.01 Million	-22,330 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$33.33 - $44.6 $486,851 - $651,472	14,607 Added 189.14%	22,330 $833,000
Q4 2021 Feb 02, 2022	SELL	$35.36 - $41.86 $643,445 - $761,726	-18,197 Reduced 70.2%	7,723 $308,000
Q3 2021 Nov 08, 2021	BUY	$37.01 - $44.74 $622,101 - $752,034	16,809 Added 184.49%	25,920 $964,000
Q2 2021 Aug 09, 2021	SELL	$37.95 - $49.37 $1.74 Million - $2.26 Million	-45,839 Reduced 83.42%	9,111 $385,000
Q1 2021 May 13, 2021	BUY	$46.8 - $68.92 $1.56 Million - $2.3 Million	33,316 Added 154.0%	54,950 $2.6 Million
Q4 2020 Feb 09, 2021	BUY	$47.96 - $67.64 $27,529 - $38,825	574 Added 2.73%	21,634 $1.32 Million
Q3 2020 Nov 12, 2020	BUY	$45.41 - $57.07 $956,334 - $1.2 Million	21,060 New	21,060 $985,000

223

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.81B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.